Canney, P A <br/><br/>
A feasibility study of the efficacy and tolerability of the combination of Exemestane with the COX-2 inhibitor Celecoxib in post-menopausal patients with advanced breast cancer.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Nov 2006 
 - 2751-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2006.08.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Androstadienes--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Celecoxib<br/>Cyclooxygenase 2 Inhibitors--administration & dosage<br/>Disease-Free Survival<br/>Feasibility Studies<br/>Female<br/>Humans<br/>Middle Aged<br/>Postmenopause<br/>Pyrazoles--administration & dosage<br/>Quality of Life<br/>Sulfonamides--administration & dosage<br/>Treatment Outcome